BAFNA PHARMACEUTICALS LTD.
BSE: 532989
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 26.58-37.1% | 42.24+10.3% | 38.29+7.9% | 35.47+2.4% | 34.62-11.4% | 39.06+17.7% | 33.19-17.7% | 40.32 |
| Other Income | 1.91+8.5% | 1.76+44.5% | 1.22+3.4% | 1.18+98.1% | 0.60-41.9% | 1.02+439.5% | 0.19-81.4% | 1.02 |
| Total Income | 28.49-35.2% | 44.00+11.4% | 39.51+7.8% | 36.65+4.1% | 35.22-12.1% | 40.09+20.1% | 33.38-19.3% | 41.34 |
| EXPENSES | ||||||||
| Expenditure | 28.42-31.3% | 41.38+9.9% | 37.67+12.4% | 33.52+5.3% | 31.83-13.9% | 36.99+14.1% | 32.42-16.3% | 38.73 |
| Tax | 0.00+100.0% | -0.13 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
| PROFIT | ||||||||
| PBT | 0.08-97.1% | 2.62+42.6% | 1.84-41.2% | 3.12-7.8% | 3.39+158.5% | 1.31+38.3% | 0.95-63.8% | 2.62 |
| Net Profit | 0.08-97.3% | 2.75+49.7% | 1.84-41.2% | 3.12-7.8% | 3.39+158.5% | 1.31+38.3% | 0.95-63.8% | 2.62 |
| KEY METRICS | ||||||||
| OPM % | 3.32%-5.08pp | 8.40%+0.43pp | 7.97%-4.10pp | 12.07%-2.57pp | 14.64%+11.25pp | 3.39%+8.01pp | -4.62%-3.12pp | -1.50% |
| NPM % | 0.26%-5.99pp | 6.25%+1.60pp | 4.65%-3.88pp | 8.53%-1.09pp | 9.62%+6.35pp | 3.27%+0.43pp | 2.84%-3.49pp | 6.33% |
| EPS | 0.03-97.4% | 1.16+48.7% | 0.78-40.9% | 1.32-7.7% | 1.43+160.0% | 0.55+37.5% | 0.40-64.0% | 1.11 |
Corporate Events
Board MeetingBAFNAPH
202611Nov
Board Meeting
The meeting of the Board of Directors is scheduled to be hel…
BSE Filing ↗ Board MeetingBAFNAPH
202611Sep
Board Meeting
The 31st Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗ Board MeetingBAFNAPH
202611Aug
Board Meeting
A meeting of the Board of Directors of the Company is schedu…
BSE Filing ↗ Board MeetingBAFNAPH
202629May
Board Meeting
The board meeting is scheduled to consider and approve the A…
BSE Filing ↗ Board MeetingBAFNAPH
202411Nov
Board Meeting
Consider and approve the Unaudited Financial Results of the …
BSE Filing ↗